From Verify.Wiki
Jump to: navigation, search

Affymax, Inc. is a biopharmaceutical company previously committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Our vision was to become a leader in the nephrology and specialty care space by delivering innovative therapeutic offerings to patients and healthcare providers before a nationwide voluntary recall of OMONTYS® (peginesatide) Injection in February 2013. In March 2013 Affymax commenced a review of strategic alternatives. 

Type Public / Private



Top 5 Recent Tweets

August 29, 2020TickerReportAffymax $AFFY Stock Passes Above 200-Day Moving Average of $0.03
August 29, 2020dailypoliticalnAffymax $AFFY Stock Passes Above 200 Day Moving Average of $0.03
August 24, 2020Jasik$AFFY 0.08 (+71.67%) $89,335 $/v with 121 trades today.

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history